Author:
Chuang Yu-Chung,Chen Pao-Yu,Lin Chi-Ying,Chen Yee-Chun,Wang Jann-Tay,Chang Shan-Chwen
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Boucher, H. W. et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 1–12 (2009).
2. Wang, J. L. & Hsueh, P. R. Therapeutic options for infections due to vancomycin-resistant enterococci. Expert Opin. Pharmacother. 10, 785–796 (2009).
3. Whang, D. W., Miller, L. G., Partain, N. M. & McKinnell, J. A. Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections. Antimicrob. Agents Chemother. 57, 5013–5018 (2013).
4. Chuang, Y. C., Wang, J. T., Lin, H. Y. & Chang, S. C. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis. BMC Infect. Dis. 14, 687 (2014).
5. Britt, N. S., Potter, E. M., Patel, N. & Steed, M. E. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients. Clin. Infect. Dis. 64, 605–613 (2017).
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献